DexCom

Almost $20 trillion in revenue—and a record-breaking $1.87 trillion in profits. Introducing the 2025 Fortune 500, the definitive list of the biggest companies in America.

Fortune 500

The Fortune 500, in its 70th year in 2024, ranks the biggest U.S. companies by revenue.

The Fortune 500, in its 69th year in 2023, ranks the biggest U.S. companies by revenue.

This year’s Fortune 500 marks the 68th running of the list.

This year’s group delivered stellar revenue and profit growth, but it underperformed the broader stock market.

100 Fastest-Growing Companies

Resilience and the capacity for reinvention have never been more important.

Future 50-2021-Dexcom

The Future 50

This year’s Fortune 500 marks the 67th running of the list.

Explore this year's ranking of the 50 companies with the best long-term growth potential.

Future 50-2020-Dexcom

<p class="p1">DexCom makes medical devices that regularly track users’ glucose levels and can send those readings to a smartphone. The technology—called continuous glucose monitoring, or CGM—offers an alternative to people with diabetes who have long had to measure their blood sugar through finger-sticking. Adoption of DexCom’s devices drove revenue up 43% last year, but the company is finding a new market during COVID-19. Hospital staffs have been using the devices to remotely monitor COVID patients’ glucose levels. Over the past five years, the stock is up 266%.</p>

Welcome to the inaugural Fortune Future 50, our new ranking of companies best positioned for breakout growth.

Fastest-growing Companies

Revenue 3 Yr Growth Rank

Revenue 3 Yr Annual Growth Rate

EPS 3 Yr Growth Rank

EPS 3 Yr Annual Growth Rate

Total Return 3 Yr Rank

Total Return 3 Yr Annual Rate (Through June 28, 2024)

Beat S&P 500 3 Yr Return (10%)

Years on List

Sector

Future 50

Overall Score

Key Financials (last Fiscal Year)

Revenues ($M)

Profits ($M)

Assets ($M)

Total Stockholder Equity ($M)

Profit Ratios

Profit as % of Revenues

Profits as % of Assets

Profits as % of Stockholder Equity

Earnings Per Share (last Fiscal Year)

Earnings Per Share ($)

EPS % Change (from prior fiscal year)

EPS % Change (5 year annual rate)

EPS % Change (10 year annual rate)

Total Return

Total Return to Investors (last year)

Total Return to Investors (5 year, annualized)

Total Return to Investors (10 year, annualized)

DexCom (DXCM): Company Profile, Stock Price, News, Rankings

legacy

dexcom

DexCom (DXCM): Company Profile, Stock Price, News, Rankings | Fortune

DexCom

DexCom in Fortune Rankings

DexCom stock chart